December 19, 2007 / 1:33 PM / 10 years ago

Alkermes gets $166.3 mln from Reliant stake sale to Glaxo

Dec 19 (Reuters) - Biotechnology company Alkermes Inc (ALKS.O) said it received $166.3 million from the sale of its stake in heart drug specialist Reliant Pharmaceuticals Inc to Europe's biggest pharmaceuticals group GlaxoSmithKline Plc (GSK.L).

An additional $7.7 million is due to Alkermes under an escrow arrangement, the company said in a statement. (Reporting by Anant Vijay Kala in Bangalore; Editing by Deepak Kannan)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below